Purchase Order 36C24726P0114
- Not listed
- Novocure Inc. was awarded a delivery order valued at $49,748.73 for Optune Plus transducers by the Department of Veterans Affairs' Veterans Integrated Service Network 10, with an ultimate completion date of January 20, 2026. The award, issued on October 20, 2025, operates under a firm fixed-price contract structure with no set-aside designation. The delivery order stems from Novocure's broader General Services Administration Federal Supply Schedule contract for Medical Equipment and Supplies...
- Novocure Inc. has been awarded a $49,748.73 firm fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 to provide transducers and related equipment rentals and services. As the prime contractor, Novocure will deliver its Optune tumor treating fields therapy devices, transducer arrays, and support directly to the VA medical center located in Portsmouth, New Hampshire. Additionally, Novocure holds a five-year, $28.85...
- The Department of Veterans Affairs, Veterans Integrated Service Network 15 (VISN 15), awarded a $49,748.73 firm fixed-price purchase order to Novocure Inc. on October 30, 2025, for the rental of Optune Plus transducers. The contract, with an ultimate completion date of March 31, 2026, will be performed in Portsmouth, New Hampshire. Novocure Inc., a foreign-owned medical device manufacturer specializing in Tumor Treating Fields (TTFields) technology, will provide non-invasive cancer treatment...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price purchase order to Novocure Inc., a foreign-owned for-profit company, for the provision of Optune Plus Transducers. Novocure is the prime contractor and will deliver the medical equipment and services directly to the VA without subcontractors. The purchase order has a potential value of $126,000.00 and a period of performance ending on March 31, 2021. Novocure also holds a 5-year Federal Supply...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 1 (VISN 1), awarded a $49,748.73 firm fixed-price delivery order to Novocure Inc. on October 29, 2025, for Optune Plus transducers with a completion date of January 28, 2026. This delivery order was issued under Novocure's existing Federal Supply Schedule (FSS) contract for Medical Equipment and Supplies (FSS-65-II-A), a $28.85 million multiple-award schedule contract effective through October 31, 2027. The award does...
- This federal contract award is for the delivery of Novocure Inc.'s Optune Plus transducers to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $49,748.73 firm-fixed-price purchase order was issued by the VA's VISN 7 network and has a performance period through March 31, 2025. Novocure, a foreign-owned, for-profit manufacturer of medical devices, is the prime contractor on this award. The contract does not utilize any set-aside designations. Novocure's Optune...
- This federal contract award is for the procurement of Optune Plus transducers from Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy. The $16,582.91 firm-fixed price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc. as the prime contractor. The contract has an ultimate completion date of March 28, 2025 and does not utilize any set-aside designations. Novocure...
- Novocure Inc. has been awarded a $49,748.73 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 to provide Optune Plus transducers. As the prime contractor, Novocure will deliver its proprietary Optune tumor treating fields therapy devices, transducer arrays, and related equipment rentals and services directly to the VA medical center located in Portsmouth, New Hampshire. This delivery order is being issued...
- This federal contract award is for the delivery of Novocure Inc.'s Optune Plus transducers to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $49,748.73 firm fixed-price purchase order was awarded on December 4, 2023 with an ultimate completion date of the same day. The contract does not utilize any set-aside designations. Novocure Inc. is a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy using its proprietary...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price purchase order to Novocure Inc., a foreign-owned for-profit organization, to provide its Optune tumor treating fields (TTFields) delivery systems, transducer arrays, rentals, and support services to VA medical centers. This $126,000.00 order was placed by the VA VHA Veterans Integrated Service Network (VISN) 23 and is for services to be performed in Portsmouth, New Hampshire. Novocure is the...
Novocure Inc. was awarded a $49,748.73 firm fixed-price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 7 on November 5, 2025, for Optune Plus transducers. The contract, which carries no set-aside designation, is scheduled for completion by February 27, 2026, and will be performed in Portsmouth, New Hampshire. This award represents a delivery order under Novocure's existing Federal Supply Schedule contract with the VA Veterans Health Administration for Medical Equipment and Supplies (FSS-65-II-A), a $28.85 million multiple-award vehicle established in November 2022 through October 2027. Novocure Inc., a foreign-owned medical device manufacturer specializing in Tumor Treating Fields (TTFields) technology, delivers innovative cancer therapy solutions to VA medical centers nationwide. The Optune system is FDA-approved for treating solid tumors, including glioblastoma and mesothelioma, providing non-invasive treatment options for veteran patients. As the prime contractor performing this work directly without subcontractors, Novocure continues its established role as a critical provider of advanced cancer treatment technologies across the VA's integrated service networks. The transducers being procured under this order support the delivery of cutting-edge therapeutic devices that expand veterans' access to specialized medical treatments.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.7k | 11/5/25 |